SCHEMBL769583

SCHEMBL769583

O=C(c1ccccc1OCO)c1ccccc1S(=O)(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.41
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.38
PTK2B Q14289 1/20 0.38
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HTT P42858 1/20 0.37
HCRTR1 O43613 2/20 0.37
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD3 P35462 1/20 0.36
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
ABCB1 P08183 2/20 0.35
CA5A P35218 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18817856 0.98 ELANE (0.41) ELANEALDH1A1KMT2APTK2BLMNA
SCHEMBL579428 0.85 ELANE (0.40) ELANEALDH1A1KMT2APTK2BLMNA
SCHEMBL489857 0.85 ALDH1A1 (0.48) ELANEALDH1A1KMT2APTK2BLMNA
SCHEMBL10886678 0.81 HSD17B10 (0.38) ELANEALDH1A1KMT2ALMNASMN1; SMN2
SCHEMBL31297149 0.81 HSD17B10 (0.38) ELANEALDH1A1KMT2ALMNASMN1; SMN2
SCHEMBL1161086 0.81 CA1 (0.44) ELANEALDH1A1KMT2ALMNASMN1; SMN2
Sulfuric Acid SCHEMBL28055088 0.79 DRD2 (0.52) ELANEALDH1A1KMT2APTK2BLMNA
SCHEMBL8431035 0.78 ELANE (0.41) ELANEALDH1A1KMT2ALMNAKDM4E
SCHEMBL30149165 0.75 DRD2 (0.57) ELANEALDH1A1KMT2APTK2BKDM4E
SCHEMBL769670 0.75 DRD2 (0.57) ELANEALDH1A1KMT2APTK2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2543356-B1 SUNBLOCK COMPOSITION SHISEIDO CO LTD (JP) 2017-01-04 EP claimed
EP-2172185-B1 Cosmetic material comprising octyl hydroxy stearate oligomer PARAHERMOSA CO LTD (JP) 2011-11-23 EP claimed
US-7964180-B2 Method for enhancing effects of colorants and conditioners E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-21 US claimed
EP-2332512-A1 Method for enhancing effects of colorants and conditioners E. I. du Pont de Nemours and Company (US) 2011-06-15 EP claimed
US-20100189670-A1 METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-07-29 US claimed
US-7658769-B2 Oxidation hair dye composition HOYU CO., LTD. (JP) 2010-02-09 US claimed
EP-2099493-A1 PEPTIDE-BASED HAIR PROTECTANTS E. I. Du Pont de Nemours and Company (US) 2009-09-16 EP claimed
US-20090089940-A1 Oxidation Hair Dye Composition HOYU CO., LTD. (JP) 2009-04-09 US claimed
EP-1948319-A2 PEPTIDE-BASED ORGANIC SUNSCREENS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-07-30 EP claimed
US-20080175798-A1 PEPTIDE-BASED HAIR PROTECTANTS E. I. DU PONT DE NEMOURS AND COMPANY 2008-07-24 US claimed
WO-2008073368-A1 PEPTIDE-BASED HAIR PROTECTANTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-06-19 WO claimed
EP-1928397-A1 METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS E.I.Du pont de nemours and company (US) 2008-06-11 EP claimed
WO-2007059076-A2 PEPTIDE-BASED ORGANIC SUNSCREENS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-24 WO claimed
US-20070110686-A1 Peptide-based organic sunscreens E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-17 US claimed
WO-2007038733-A1 METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-04-05 WO claimed
US-20070067924-A1 Method for enhancing effects of colorants and conditioners E. I. DU PONT DE NEMOURS AND COMPANY 2007-03-29 US claimed
US-12036306-B2 Cosmetic product SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-07-16 US disclosed
US-20240216272-A1 PHARMACEUTICAL PREPARATION KOWA COMPANY, LTD. (JP) 2024-07-04 US disclosed
EP-0662314-B1 Method of hair treatment KAO CORP (JP) 1999-11-03 EP disclosed
EP-0662314-A1 Method of hair treatment Kao Corporation (JP) 1995-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216272-A1 PHARMACEUTICAL PREPARATION SFPQ, HAX1, XDH ELANE 2796/4885ALDH1A1 755/4885KMT2A 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.